New psoriasis drug begins human testing
NCT ID NCT07051538
Summary
This early-stage study tested a new injection called SHR-1139 to see if it's safe for people. Researchers gave single doses to healthy volunteers and multiple doses to patients with moderate-to-severe plaque psoriasis. The main goal was to check for side effects and see how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, 200031, China
Conditions
Explore the condition pages connected to this study.